Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors

Diabetic Medicine

Volumn 19, Issue 9, 2002, Pages 771-776

  Van De Poll Franse, L V ^a,d   Valk, G D ^a,b   Renders, C M ^a   Heine, R J ^a,b   Van Eijk, J T M ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d The Netherlands   (Netherlands)

Author keywords

Diabetic polyneuropathy; Neurological examination; Primary health care; Prospective study; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACHILLES REFLEX; ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRICK TEST; RISK ASSESSMENT; RISK FACTOR; TOUCH; VIBRATION SENSE;

AGE OF ONSET; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0036042685     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00778.x     Document Type: Article

References (30)

1. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
2. Pathogenesis of diabetic neuropathy
3. Diabetic neuropathy: Scope of the syndrome
4. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
5. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy
6. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
7. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study
8. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study
9. Hypertension as a risk factor for diabetic neuropathy: A prospective study
10. Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort
11. Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy
12. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort
13. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy
14. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy
15. The assessment of diabetic polyneuropathy in daily clinical practice: Reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination
16. 'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients
17. Evaluation of postural stability in elderly with diabetic neuropathy
18. Postural stability in diabetic polyneuropathy
19. Influence of height on quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy
20. Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: A population-based 7-year follow-up study
21. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects
22. Height is an independent risk factor for neuropathy in diabetic men
23. Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy
24. Body mass index effect on common nerve conduction study measurements
25. Simple screening tests for peripheral neuropathy in the diabetes clinic
26. NHG Standard Diabetes Mellitus Type 2